Joel Greenblatt’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$217K Hold
10,100
– – ﹤0.01% 1787
2026
Q2
$214K Hold
10,100
– – ﹤0.01% 1720
2026
Q1
$221K Hold
10,100
– – ﹤0.01% 1670
2025
Q4
$217K Sell
10,100
-100
-1% -$1.76K ﹤0.01% 1642
2025
Q3
$119K Hold
10,200
– – ﹤0.01% 1644
2025
Q2
$94.9K Hold
10,200
– – ﹤0.01% 1618
2025
Q1
$68.6K Buy
+10,200
New +$97.9K ﹤0.01% 1523

Other funds holding IMNM

Joel Greenblatt's IMNM Position: Q3 2026 in Review

Joel Greenblatt held its Immunome (IMNM) position steady in Q3 2026 at 10,100 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

Joel Greenblatt first reported a position in IMNM in Q1 2025 and has held it in 7 quarters since. The position peaked at $221K in Q1 2026. 211 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • Joel Greenblatt held 10,100 shares of Immunome worth $217K as of Q3 2026.
  • Joel Greenblatt left its Immunome share count unchanged in Q3 2026.
  • Immunome made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1787 holding.
  • Joel Greenblatt first reported a position in Immunome in Q1 2025 and has held it in 7 quarters since.
  • Joel Greenblatt's Immunome position peaked at $221K in Q1 2026.
  • 211 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.